Profile
David Green worked as an Executive Director of Clinical Operations at Amgen, Inc. from 1997 to 2008.
He also worked as an Executive Director at United Therapeutics Corp., a Clinical Program Manager at Abbott Laboratories, and a Vice President of Global Clinical Operations at both Aquinox Pharmaceuticals, Inc. and ReSearch Pharmaceutical Services, Inc.
Former positions of David Green
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2008-01-31 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
| UNITED THERAPEUTICS CORPORATION | Director/Board Member | - |
| ReSearch Pharmaceutical Services, Inc. | Chief Tech/Sci/R&D Officer | - |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| AMGEN INC. | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
| ReSearch Pharmaceutical Services, Inc. |
- Stock Market
- Insiders
- David Green
